PharmaCielo Ltd., a Canadian cannabis company, announced a significant increase in revenue for the second quarter of 2024, driven by strong sales of cannabis derivative products. Despite the revenue growth, the company’s net loss narrowed slightly compared to the previous quarter. PharmaCielo is focused on optimizing its capital structure and building a robust sales pipeline in the emerging global cannabis market.